- Report
- November 2023
- 130 Pages
Global
From €1754EUR$1,950USD£1,545GBP
- Report
- August 2024
- 120 Pages
Global
From €5351EUR$5,950USD£4,714GBP
- Report
- March 2023
- 130 Pages
Japan
From €2239EUR$2,490USD£1,973GBP
- Report
- March 2023
- 190 Pages
Germany
From €2239EUR$2,490USD£1,973GBP
- Report
- March 2023
- 190 Pages
Switzerland
From €2239EUR$2,490USD£1,973GBP
- Report
- February 2023
- 130 Pages
France
From €2239EUR$2,490USD£1,973GBP
- Report
- February 2023
- 130 Pages
Canada
From €2239EUR$2,490USD£1,973GBP
- Report
- February 2023
- 120 Pages
Israel
From €2239EUR$2,490USD£1,973GBP
- Report
- September 2020
- 168 Pages
Netherlands
From €1790EUR$1,990USD£1,576GBP
- Report
- January 2023
- 180 Pages
Netherlands
From €2239EUR$2,490USD£1,973GBP
- Report
- July 2025
- 200 Pages
Saudi Arabia
From €2239EUR$2,490USD£1,973GBP
- Report
- November 2024
- 70 Pages
Australia
From €2239EUR$2,490USD£1,973GBP
- Report
- July 2023
- 220 Pages
Global
From €1790EUR$1,990USD£1,576GBP
- Report
- February 2023
- 190 Pages
Sweden
From €2239EUR$2,490USD£1,973GBP
- Report
- January 2023
- 190 Pages
United Kingdom
From €2239EUR$2,490USD£1,973GBP
- Report
- January 2023
- 125 Pages
United States
From €2239EUR$2,490USD£1,973GBP
- Report
- July 2021
- 50 Pages
China
From €2338EUR$2,600USD£2,060GBP
- Report
- June 2021
- 50 Pages
China
From €2338EUR$2,600USD£2,060GBP
- Report
- June 2021
- 50 Pages
China
From €2338EUR$2,600USD£2,060GBP
- Report
- May 2021
- 50 Pages
China
From €2338EUR$2,600USD£2,060GBP

The Diabetes Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat diabetes. Diabetes is a chronic condition that affects millions of people worldwide, and the drugs used to treat it can help to manage the symptoms and reduce the risk of complications. Commonly prescribed diabetes drugs include insulin, sulfonylureas, meglitinides, thiazolidinediones, and DPP-4 inhibitors. These drugs are used to help regulate blood sugar levels, reduce insulin resistance, and improve the body's ability to use insulin.
Some of the major companies in the Diabetes Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the research, development, and marketing of diabetes drugs, and they are constantly striving to develop new and improved treatments for the condition. Show Less Read more